Hormel Foods is most often covered alongside Jennie-O Turkey Store, which appears in 3 of these 3 stories. The 7-day window averages about 3 stories each week. The busiest single day carried 2. Coverage clusters in earnings, which accounts for 2 of those 3, with the remainder spread across 1 other category.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Hormel Foods
Hormel Foods is most often covered alongside Jennie-O Turkey Store, which appears in 3 of these 3 stories. The 7-day window averages about 3 stories each week. The busiest single day carried 2. Coverage clusters in earnings, which accounts for 2 of those 3, with the remainder spread across 1 other category. Each carries 2.3 original sources on average. We currently track 3 Cross-Sector stories that mention Hormel Foods, published between February 19, 2026 and February 25, 2026.
Stories tracked
3
Per week
3
Sources per story
2.3
Computed from the 3 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Hormel Foods. Shared-story counts are live from our verified record — not editorial picks.
Hormel Foods and Celsius Holdings are set to report Q4 results, highlighting a sharp divergence between legacy protein producers and high-growth functional beverages. Investors are closely monitoring Hormel's margin recovery and Celsius's inventory stabilization following recent distribution shifts with PepsiCo.
Hormel Foods and Celsius Holdings are set to report Q4 results, highlighting a divergence in the consumer goods sector between defensive staples and high-velocity functional beverages. While Hormel navigates commodity volatility and brand revitalization, Celsius faces scrutiny over its distribution scaling and market share retention.
Hormel Foods has entered a definitive agreement to sell its commodity-focused whole-bird turkey business to Life-Science Innovations. The strategic divestiture aims to reduce exposure to seasonal volatility and pivot the company's turkey portfolio toward higher-margin, value-added products.